These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8726790)

  • 1. A double-blind, multicentre study of paroxetine and maprotiline in major depression.
    Schnyder U; Koller-Leiser A
    Can J Psychiatry; 1996 May; 41(4):239-44. PubMed ID: 8726790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind study comparing paroxetine and maprotiline in depressed outpatients.
    Szegedi A; Wetzel H; Angersbach D; Dunbar GC; Schwarze H; Philipp M; Benkert O
    Pharmacopsychiatry; 1997 May; 30(3):97-105. PubMed ID: 9211571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to treatment in minor and major depression: results of a double-blind comparative study with paroxetine and maprotiline.
    Szegedi A; Wetzel H; Angersbach D; Philipp M; Benkert O
    J Affect Disord; 1997 Sep; 45(3):167-78. PubMed ID: 9298430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression.
    de Jonghe F; Swinkels J; Tuynman-Qua H
    Pharmacopsychiatry; 1991 Jan; 24(1):21-7. PubMed ID: 1901418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose escalation vs. continued doses of paroxetine and maprotiline: a prospective study in depressed out-patients with inadequate treatment response.
    Benkert O; Szegedi A; Wetzel H; Staab HJ; Meister W; Philipp M
    Acta Psychiatr Scand; 1997 Apr; 95(4):288-96. PubMed ID: 9150822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients.
    Claghorn JL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():33-5. PubMed ID: 1531821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of major depression in general practice: a double-blind comparison of paroxetine and lofepramine.
    Moon CA; Vince M
    Br J Clin Pract; 1996; 50(5):240-4. PubMed ID: 8794599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine.
    Waintraub L; Septien L; Azoulay P
    CNS Drugs; 2002; 16(1):65-75. PubMed ID: 11772119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter double-blind study of moclobemide and maprotiline.
    Vaz-Serra A; Figueira ML; Firmino H; Albuquerque AJ; Jara JM; Pestana LC
    Clin Neuropharmacol; 1994; 17 Suppl 1():S38-49. PubMed ID: 7954483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind study of fluoxetine and maprotiline in the treatment of major depression.
    de Jonghe F; Ravelli DP; Tuynman-Qua H
    Pharmacopsychiatry; 1991 Mar; 24(2):62-7. PubMed ID: 1852793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A placebo- and imipramine-controlled study of paroxetine.
    Cohn JB; Crowder JE; Wilcox CS; Ryan PJ
    Psychopharmacol Bull; 1990; 26(2):185-9. PubMed ID: 2146697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
    Baldwin DS; Hawley CJ; Abed RT; Maragakis BP; Cox J; Buckingham SA; Pover GH; Ascher A
    J Clin Psychiatry; 1996; 57 Suppl 2():46-52. PubMed ID: 8626363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paroxetine versus placebo: a double-blind comparison in depressed patients.
    Claghorn JL; Kiev A; Rickels K; Smith WT; Dunbar GC
    J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients.
    Stuppaeck CH; Geretsegger C; Whitworth AB; Schubert H; Platz T; König P; Hinterhuber H; Fleischhacker WW
    J Clin Psychopharmacol; 1994 Aug; 14(4):241-6. PubMed ID: 7962679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy and tolerability of moclobemide and maprotiline in depressed patients treated by general practitioners.
    Gachoud JP; Dick P; Köhler M
    Clin Neuropharmacol; 1994; 17 Suppl 1():S29-37. PubMed ID: 7954482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.
    Dunner DL; Cohn JB; Walshe T; Cohn CK; Feighner JP; Fieve RR; Halikas JP; Hartford JT; Hearst ED; Settle EC
    J Clin Psychiatry; 1992 Feb; 53 Suppl():57-60. PubMed ID: 1531827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients.
    De Wilde J; Spiers R; Mertens C; Bartholomé F; Schotte G; Leyman S
    Acta Psychiatr Scand; 1993 Feb; 87(2):141-5. PubMed ID: 8447241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of a clinical trial of levoprotiline].
    Höschl C; Filip V; Bornová L; David I; Karen P; Seifertová D
    Cesk Psychiatr; 1992 Jun; 88(2):97-105. PubMed ID: 1505054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
    McElroy SL; Weisler RH; Chang W; Olausson B; Paulsson B; Brecher M; Agambaram V; Merideth C; Nordenhem A; Young AH;
    J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.